149 related articles for article (PubMed ID: 15468331)
1. Role of DNA mismatch repair in apoptotic responses to therapeutic agents.
Meyers M; Hwang A; Wagner MW; Boothman DA
Environ Mol Mutagen; 2004; 44(4):249-64. PubMed ID: 15468331
[TBL] [Abstract][Full Text] [Related]
2. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
[TBL] [Abstract][Full Text] [Related]
3. Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells.
Papouli E; Cejka P; Jiricny J
Cancer Res; 2004 May; 64(10):3391-4. PubMed ID: 15150090
[TBL] [Abstract][Full Text] [Related]
4. Targeting DNA mismatch repair for radiosensitization.
Berry SE; Kinsella TJ
Semin Radiat Oncol; 2001 Oct; 11(4):300-15. PubMed ID: 11677655
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
Tronov VA; Kramarenko II; Smirnova TD; Terekhov SM
Tsitologiia; 2006; 48(1):19-27. PubMed ID: 16568831
[TBL] [Abstract][Full Text] [Related]
6. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
[TBL] [Abstract][Full Text] [Related]
7. Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells.
de Castro E Gloria H; Jesuíno Nogueira L; Bencke Grudzinski P; da Costa Ghignatti PV; Guecheva TN; Motta Leguisamo N; Saffi J
BMC Cancer; 2021 Apr; 21(1):448. PubMed ID: 33888065
[TBL] [Abstract][Full Text] [Related]
8. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
Robinson BW; Im MM; Ljungman M; Praz F; Shewach DS
Cancer Res; 2003 Oct; 63(20):6935-41. PubMed ID: 14583494
[TBL] [Abstract][Full Text] [Related]
9. DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance.
Lin X; Howell SB
Mol Cancer Ther; 2006 May; 5(5):1239-47. PubMed ID: 16731756
[TBL] [Abstract][Full Text] [Related]
10. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
11. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
12. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins.
Bellacosa A
Cell Death Differ; 2001 Nov; 8(11):1076-92. PubMed ID: 11687886
[TBL] [Abstract][Full Text] [Related]
13. Mismatch repair and DNA damage signalling.
Stojic L; Brun R; Jiricny J
DNA Repair (Amst); 2004; 3(8-9):1091-101. PubMed ID: 15279797
[TBL] [Abstract][Full Text] [Related]
14. The role of DNA mismatch repair in drug resistance.
Fink D; Aebi S; Howell SB
Clin Cancer Res; 1998 Jan; 4(1):1-6. PubMed ID: 9516945
[TBL] [Abstract][Full Text] [Related]
15. Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.
Hassen S; Ali AA; Kilaparty SP; Al-Anbaky QA; Majeed W; Boman BM; Fields JZ; Ali N
Mol Cell Biochem; 2016 Jan; 412(1-2):297-305. PubMed ID: 26728996
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.
Hawn MT; Umar A; Carethers JM; Marra G; Kunkel TA; Boland CR; Koi M
Cancer Res; 1995 Sep; 55(17):3721-5. PubMed ID: 7641183
[TBL] [Abstract][Full Text] [Related]
17. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
[TBL] [Abstract][Full Text] [Related]
18. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents.
Vernole P; Pepponi R; D'Atri S
Cancer Chemother Pharmacol; 2003 Sep; 52(3):185-92. PubMed ID: 12827294
[TBL] [Abstract][Full Text] [Related]
19. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
Moreland NJ; Illand M; Kim YT; Paul J; Brown R
Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
[TBL] [Abstract][Full Text] [Related]
20. Mismatch repair proficiency and in vitro response to 5-fluorouracil.
Carethers JM; Chauhan DP; Fink D; Nebel S; Bresalier RS; Howell SB; Boland CR
Gastroenterology; 1999 Jul; 117(1):123-31. PubMed ID: 10381918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
